Status:

WITHDRAWN

Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

Lead Sponsor:

Hull University Teaching Hospitals NHS Trust

Collaborating Sponsors:

Galen Limited

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

40-80 years

Phase:

PHASE4

Brief Summary

This is a parallel group, double-blind, placebo controlled, multi-centre, randomised trial. 60 patients to be included who are adult patients admitted to hospital with a clinical diagnosis of acute e...

Eligibility Criteria

Inclusion

  • Male/females aged between 40-80 years
  • Previous diagnosis of COPD
  • Acute exacerbation of COPD requiring treatment with antibiotics and/or corticosteroids
  • Symptoms of increased breathlessness, cough, sputum volume or sputum purulence
  • Acute exacerbation of COPD hospitalised within 24hrs of study participation.
  • On a stable therapeutic regimen for COPD for 8 weeks prior to inclusion
  • Known history of cigarette smoking at least 10 pack yrs
  • Willing and able to comply with study procedures
  • Able to provide written informed consent to participate

Exclusion

  • Acute exacerbation of COPD within 8 weeks prior to inclusion
  • Arterial blood gas on admission \< pH 7.26
  • Currently on treatment with mucolytics
  • Patients suffering from post nasal drip, or gastro-oesophageal reflux disease
  • Clinically significant or unstable concurrent disease e.g. left ventricular failure, diabetes mellitus
  • On long-term oxygen therapy
  • Known or suspected hypersensitivity to erdosteine

Key Trial Info

Start Date :

August 10 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 13 2012

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01176318

Start Date

August 10 2010

End Date

January 13 2012

Last Update

June 19 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Castle Hill Hospital

Cottingham, East Yorkshire, United Kingdom, HU16 5JQ

Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) | DecenTrialz